Objective: To evaluate the results of treatment with an insulin glargine-based regimen as compared with those of an NPH insulin-based regimen.
Methods: We reviewed the charts of 83 Japanese patients with Type 1 diabetes treated with insulin glargine for 12 months.
Patients: Median age, 56.